RU98117621A - NEW DERIVATIVES OF PIPERASIN AND PIPERIDINE, METHOD FOR PRODUCING THEM, PHARMACEUTICAL COMPOSITION ON THEIR BASIS, METHOD OF TREATMENT, INTERMEDIATE PRODUCT - Google Patents

NEW DERIVATIVES OF PIPERASIN AND PIPERIDINE, METHOD FOR PRODUCING THEM, PHARMACEUTICAL COMPOSITION ON THEIR BASIS, METHOD OF TREATMENT, INTERMEDIATE PRODUCT

Info

Publication number
RU98117621A
RU98117621A RU98117621/04A RU98117621A RU98117621A RU 98117621 A RU98117621 A RU 98117621A RU 98117621/04 A RU98117621/04 A RU 98117621/04A RU 98117621 A RU98117621 A RU 98117621A RU 98117621 A RU98117621 A RU 98117621A
Authority
RU
Russia
Prior art keywords
group
formula
compound
salts
alkyl
Prior art date
Application number
RU98117621/04A
Other languages
Russian (ru)
Other versions
RU2197488C2 (en
Inventor
Рулоф Виллем Фенстра
Хартог Якобус Антониус Йосеф Ден
Корнелис Геррит Крюсе
Мартинус Теодорус Мария Тюлп
Стивен Кеннет Лонг
Original Assignee
Дюфар Интернэшнл Рисерч Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дюфар Интернэшнл Рисерч Б.В. filed Critical Дюфар Интернэшнл Рисерч Б.В.
Publication of RU98117621A publication Critical patent/RU98117621A/en
Application granted granted Critical
Publication of RU2197488C2 publication Critical patent/RU2197488C2/en

Links

Claims (6)

1. Производные пиперазина и пиперидина общей формулы
Figure 00000001

А представляет гетероциклическую группу с 5 - 7 атомами в кольце, где присутствуют 1 - 3 гетероатома, из группы O, N и S,
R1 представляет водород или фтор,
R2 представляет С1-4-алкил, С1-4-алкокси или оксо - группу и р равно 0, 1 или 2,
Z представляет углерод или азот и пунктирная линия представляет одинарную связь, когда Z представляет азот, и одинарную или двойную связь, когда Z представляет углерод,
R3 и R4 независимо, представляют водород или С1-4-алкил,
n равно 1 или 2,
R5 представляет 2-пиридил, 3-пиридил или 4-пиридил, замещенный в мета-положении относительно метиленового мостика группой Y и необязательно замещенный заместителем (R6)q,
Y представляет фенил, фуранил или тиенил, причем эти группы могут быть замещены 1 - 3 заместителями из группы, включающей гидрокси, галоген, CF3, C1-4-алкокси, С1-4-алкил, циано, аминокарбонил, моно- или ди-С1-4-алкиламинокарбонил,
R6 представляет галоген, гидрокси, С1-4-алкокси или С1-4 алкил, и q равно 0, 1, 2 или 3, и их соли.
1. Derivatives of piperazine and piperidine of the General formula
Figure 00000001

A represents a heterocyclic group with 5 to 7 atoms in the ring, where 1 to 3 heteroatoms are present, from the group O, N and S,
R 1 represents hydrogen or fluorine,
R 2 represents a C 1-4 alkyl, a C 1-4 alkoxy or oxo group and p is 0, 1 or 2,
Z represents carbon or nitrogen and the dotted line represents a single bond when Z represents nitrogen, and a single or double bond when Z represents carbon,
R 3 and R 4 independently represent hydrogen or C 1-4 alkyl,
n is 1 or 2,
R 5 represents 2-pyridyl, 3-pyridyl or 4-pyridyl substituted in the meta position relative to the methylene bridge with group Y and optionally substituted with the substituent (R 6 ) q ,
Y represents phenyl, furanyl or thienyl, these groups being optionally substituted with 1 to 3 substituents from the group consisting of hydroxy, halogen, CF 3 , C 1-4 alkoxy, C 1-4 alkyl, cyano, aminocarbonyl, mono- or di-C 1-4 -alkylaminocarbonyl,
R 6 represents halogen, hydroxy, C 1-4 alkoxy or C 1-4 alkyl, and q is 0, 1, 2 or 3, and their salts.
2. Соединение по п.1, в котором А вместе с фенильной группой представляет группу формулы b, c, d, e, f или g:
Figure 00000002

Figure 00000003

Figure 00000004

и n равно 1, и R1 и (R2)p, R3, R4, R5, (R6)q, Y и Z имеют значения, данные в п.1, и его соли.
2. The compound according to claim 1, in which a together with a phenyl group represents a group of the formula b, c, d, e, f or g:
Figure 00000002

Figure 00000003

Figure 00000004

and n is 1, and R 1 and (R 2 ) p , R 3 , R 4 , R 5 , (R 6 ) q , Y and Z have the meanings given in claim 1, and its salts.
3. Соединение по п.2, в котором А вместе с фенильной группой представляет группу формулы (с) или (d), где R5 имеет значения, данные в п.1, Y представляет фенил, R3 и R4 представляет водород, R6 представляет гидрокси группу, метокси или галоген, q равно 0 или 1, Z представляет азот, и его соли.3. The compound according to claim 2, in which A together with a phenyl group represents a group of the formula (c) or (d), where R 5 is as defined in claim 1, Y represents phenyl, R 3 and R 4 represents hydrogen, R 6 represents a hydroxy group, methoxy or halogen, q is 0 or 1, Z is nitrogen, and its salts. 4. Соединение по п.3, в котором А вместе с фенильной группой представляет группу формулы (d), R1, (R2)p, R3 и R4 представляют водород, n равно 1, Z представляет азот, и R5 представляет группу 5-(4-фторфенил)-пирид-3-ил, и его соли.4. The compound according to claim 3, in which A together with a phenyl group represents a group of formula (d), R 1 , (R 2 ) p , R 3 and R 4 represent hydrogen, n is 1, Z is nitrogen, and R 5 represents the group 5- (4-fluorophenyl) -pyrid-3-yl, and its salts. 5. Способ получения производных пиперазина и пиперидина формулы 1, определенной в п.1, отличающийся тем, что осуществляют: а) реакцию соединения формулы:
Figure 00000005

с соединением формулы R5 - CH2 - X, где Х представляет отщепляемую группу, где значения R1, R2, R3, R4, A, Z, p и n указаны в п.1, или в) реакцию соединения формулы:
Figure 00000006

где R'5 имеет такие же значения, как R5, подразумевая, что атом брома находится в мета-положении относительно метиленового мостика, с соединением формулы В(ОН)2-Y, где R1, R2, R3, R4, A, Z, p и n имеют значения, данные в п.1.
5. A method of obtaining derivatives of piperazine and piperidine of the formula 1, as defined in claim 1, characterized in that they carry out: a) a reaction of a compound of the formula:
Figure 00000005

with a compound of the formula R 5 - CH 2 - X, where X is a leaving group, wherein the values of R 1 , R 2 , R 3 , R 4 , A, Z, p and n are indicated in claim 1, or c) a reaction of a compound of the formula :
Figure 00000006

where R ' 5 has the same meanings as R 5 , meaning that the bromine atom is in the meta position relative to the methylene bridge, with a compound of formula B (OH) 2 -Y, where R 1 , R 2 , R 3 , R 4 , A, Z, p and n have the meanings given in claim 1.
6. Соединение формулы
Figure 00000007

где R1, (R2)p, Z, n, R3 и R4 имеют значение, данное в п.1, и R'5 имеет значение, указанное в п.5.
6. The compound of the formula
Figure 00000007

where R 1 , (R 2 ) p , Z, n, R 3 and R 4 have the meaning given in claim 1, and R ' 5 has the meaning indicated in claim 5.
RU98117621/04A 1997-09-24 1998-09-21 Derivatives of piperazine RU2197488C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97202950.8 1997-09-24
EP97202950 1997-09-24

Publications (2)

Publication Number Publication Date
RU98117621A true RU98117621A (en) 2000-06-20
RU2197488C2 RU2197488C2 (en) 2003-01-27

Family

ID=8228755

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98117621/04A RU2197488C2 (en) 1997-09-24 1998-09-21 Derivatives of piperazine

Country Status (31)

Country Link
US (2) US6090812A (en)
EP (1) EP0908458B1 (en)
JP (1) JP4191826B2 (en)
KR (1) KR100632188B1 (en)
CN (1) CN1093857C (en)
AR (1) AR017127A1 (en)
AT (1) ATE316529T1 (en)
AU (1) AU733526B2 (en)
BR (1) BR9803497A (en)
CA (1) CA2247734C (en)
CY (1) CY1107494T1 (en)
CZ (1) CZ296741B6 (en)
DE (1) DE69833297T2 (en)
DK (1) DK0908458T3 (en)
DZ (1) DZ2613A1 (en)
ES (1) ES2255127T3 (en)
HK (1) HK1018272A1 (en)
HU (1) HU227422B1 (en)
ID (1) ID20895A (en)
IL (1) IL126295A (en)
NO (1) NO312835B1 (en)
NZ (1) NZ331984A (en)
PL (1) PL190622B1 (en)
PT (1) PT908458E (en)
RU (1) RU2197488C2 (en)
SI (1) SI0908458T1 (en)
SK (1) SK285205B6 (en)
TR (1) TR199801866A1 (en)
TW (1) TW530054B (en)
UA (1) UA66756C2 (en)
ZA (1) ZA988749B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200994B1 (en) 1999-01-07 2001-03-13 American Home Products Corp 1,4-Disubstituted cyclohexane derivatives for the treatment of depression
WO2000040579A1 (en) * 1999-01-07 2000-07-13 American Home Products Corporation New 1,4-disubstituted cyclohexane derivatives for the treatment of depression
DE10005150A1 (en) * 2000-02-07 2001-08-09 Merck Patent Gmbh Process for the preparation of 5-arylnicotinaldehydes
DE10115922A1 (en) * 2001-03-30 2002-10-10 Bayer Ag Cyclically substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
EP1408976B3 (en) 2001-07-20 2010-08-25 Psychogenics Inc. Treatment for attention-deficit hyperactivity disorder
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7405216B2 (en) 2004-08-18 2008-07-29 Solvay Pharmaceuticals, B.V. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7423040B2 (en) 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US7964604B2 (en) 2005-02-18 2011-06-21 Solvay Pharmaceuticals B.V. Bifeprunox mesylate maintenance dose compositions and methods for using the same
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
AU2007247251B2 (en) 2006-05-02 2011-11-03 Solvay Pharmaceuticals B.V. N-oxides of pyridylmethylpiperazine and -piperidine derivatives
US8106056B2 (en) 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
US7786126B2 (en) 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
WO2011088838A1 (en) 2010-01-25 2011-07-28 H. Lundbeck A/S Novel 6,6a,7,8,9,10-hexahydro-4h-4,8,10a-triaza-acephenanthrylene derivatives as dopamine d2 ligands
US8877778B2 (en) 2010-12-15 2014-11-04 Hoffmann-La Roche Inc. Benzofurane compounds
US8921397B2 (en) 2011-05-04 2014-12-30 Hoffmann-La Roche Inc. Benzofurane-piperidine compounds
TWI806385B (en) 2016-07-20 2023-06-21 瑞士商諾華公司 Aminopyridine derivatives and their use as selective alk-2 inhibitors
KR101665971B1 (en) 2016-08-10 2016-10-13 (주)글로벌 로보틱스 Automotive foam pad attachment
CN115038443A (en) 2019-11-22 2022-09-09 因西特公司 Combination therapy comprising an ALK2 inhibitor and a JAK2 inhibitor
IL298767A (en) 2020-06-16 2023-02-01 Incyte Corp Alk2 inhibitors for the treatment of anemia

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190472B1 (en) * 1984-12-21 1989-07-12 Duphar International Research B.V New pharmaceutical compositions having anti-psychotic properties
DE3586794T2 (en) 1984-12-21 1993-05-27 Duphar Int Res MEDICINAL PRODUCTS WITH PSYCHOTROPER EFFECT.
PH22783A (en) * 1986-02-27 1988-12-12 Duphar Int Res New aryl-substituted (n-piperidinyl)methyl-and (n-piperazinyl)methylazoles and pharmaceutical compositions containing the same
EP0508347A1 (en) 1991-04-10 1992-10-14 Hoechst Aktiengesellschaft 5,7-Dihydroxy-2-methyl-8-[4-(3-hydroxy-1-(1-propyl)) piperidinyl]-4H-1-benzopyran-4-one, its preparation and its use
IE914218A1 (en) * 1991-09-11 1993-03-24 Mcneilab Inc Novel 4-arylpiperazines and 4-arylpiperidines
JPH05262765A (en) 1992-03-18 1993-10-12 Sumitomo Chem Co Ltd Benzofuran derivative and herbicide containing the same as active ingredient
FR2692264B1 (en) 1992-06-12 1994-08-05 Adir NOVEL 1,4-DISUBSTITUTED PIPERAZINES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
US5332732A (en) * 1992-09-11 1994-07-26 Mcneilab, Inc. Thiophene and pyridine antipsychotic agents
US5436246A (en) * 1992-09-17 1995-07-25 Merrell Dow Pharmaceuticals Inc. Serotonin receptor agents
RU2118322C1 (en) * 1993-07-05 1998-08-27 Дюфар Интернэшнл Рисерч Б.В. 2,3-dihydro-1,4-benzodioxine-5-yl-pyrerazine derivatives and salts thereof
GB9314758D0 (en) * 1993-07-16 1993-08-25 Wyeth John & Brother Ltd Heterocyclic derivatives
EP0650964A1 (en) 1993-11-02 1995-05-03 Duphar International Research B.V 1 2H-1-benzopyran-2-one-8-yl -piperazine derivatives
DE4425146A1 (en) * 1994-07-15 1996-01-18 Basf Ag Use of heterocyclic compounds
US5607936A (en) * 1994-09-30 1997-03-04 Merck & Co., Inc. Substituted aryl piperazines as neurokinin antagonists
US6114334A (en) * 1995-07-13 2000-09-05 Knoll Aktiengesellschaft Piperazine derivatives as therapeutic agents
PL189256B1 (en) * 1996-03-29 2005-07-29 Duphar Int Res Chemical compounds of piperazine and piperidine
DE19637237A1 (en) 1996-09-13 1998-03-19 Merck Patent Gmbh Piperazine derivatives

Similar Documents

Publication Publication Date Title
RU98117621A (en) NEW DERIVATIVES OF PIPERASIN AND PIPERIDINE, METHOD FOR PRODUCING THEM, PHARMACEUTICAL COMPOSITION ON THEIR BASIS, METHOD OF TREATMENT, INTERMEDIATE PRODUCT
RU98119523A (en) COMPOUNDS OF PIPERAZIN AND PIPERIDINE
RU2403251C2 (en) 2,4-di(hetero)arylaminopyrimidine derivatives as zap-70 inhibitors
KR930005992A (en) Rukotriene Biosynthesis Inhibitor
KR870001196A (en) Pyridine compound and its preparation and pharmaceutical composition containing the same
CA2450922A1 (en) Piperidines for use as orexin receptor antagonists
RU2007139453A (en) HETEROBICYCLIC HEPATITIS C VIRUS INHIBITORS (HCV)
JP2003503311A5 (en)
RU2006101890A (en) THIAZOLYLPIPERIDINE DERIVATIVES AS BCH INHIBITORS
JP2007517044A5 (en)
EP1325921A3 (en) Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
ATE420862T1 (en) 1,2-DIHYDROPYRIDINE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
AU679761B2 (en) 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives as 5HT1A ligands
DE602005005167D1 (en) 1-ISOPROPYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXYLIC ACID AMID DERIVATIVES WITH AGONISTIC ACTIVITY AT THE 5-HT4 RECEPTOR
DE60223245D1 (en) THIAZOL AND OXAZOLE DERIVATIVES SUITABLE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND SIMILAR ILLNESSES
CY1107679T1 (en) OXAZOLYL-ARYL PROPIONIC ACID PRODUCER AND USE THEM AS PPAR AGONORS
UA66756C2 (en) Piperazine and piperidine derivatives
RU98117457A (en) COMPOUNDS OF OXA- AND TIA-DIAZOLE DERIVATIVES, METHOD FOR PRODUCING THEM, PHARMACEUTICAL COMPOSITION AND METHODS OF TREATMENT
NO20072454L (en) Pyridine derivatives, the preparation and the therapeutic use thereof
PL339994A1 (en) Novel substituted pyridine and piperidinic compounds, method of obtaining them and pharmacological compositions containing such compounds
NO176176B (en) Analogous Process for the Preparation of Therapeutically Active Arylsulfonamides
RU96102842A (en) APPLICATION OF KUMARINS AND CARBOSTERILES AS PLA2 INHIBITORS, NEW Coumarins and CARBOSTERILES, METHOD FOR PRODUCING THEM AND MEDICINES
RU97107992A (en) QUINOLINE DERIVATIVES
KR840003630A (en) Pyrimidone derivatives
HUP0303185A2 (en) Glyt-1 inhibitors